(Press-News.org) Conservative fuel treatments designed to reduce fire severity while still providing forest cover and wildlife habitat worked equally as well as more intensive treatments in allowing for the protection of homes during the 2011 Wallow Fire, a study published in the journal Forest Ecology and Management has found. The distance into the treated area where fire severity was reduced varied, however, between these different thinning approaches where fuels were reduced. The findings suggest that there may be multiple paths to fuel treatment design around the wildland-urban interface (WUI).
"Fuel reduction treatments are designed to reduce fire behavior and provide firefighters with safer opportunities to spot-protect homes, and qualitative observations during the Wallow Fire suggest previously implemented treatments did just that," said Morris Johnson, a research fire ecologist with the U.S. Forest Service's Pacific Northwest Research Station, and co-lead of the study. "Our study is the first to look quantitatively at how treatments actually performed around the wildland-urban interface during this major wildfire."
The Wallow Fire is the largest in Arizona state history, having burned over 539,000 acres between May and June 2011. Parts of the landscape that burned during the Wallow Fire previously underwent fuel reduction treatments as part of the White Mountain Stewardship Contract following another massive fire, the Rodeo-Chediski Fire, which destroyed 465 homes in 2002. This management history gave researchers an unexpected opportunity to study how effective two alternative fuel treatments were in reducing the fire's severity, particularly in the WUI, a critical area on the landscape where a forest or wildland intersects development.
Johnson and study lead Maureen Kennedy, a University of Washington research scientist, studied three previously treated areas in two WUI communities within the Wallow Fire perimeter—Alpine and Nutrioso—that burned during the fire and were not subject to fire suppression efforts. Two of the forested areas, the ones surrounding the community of Alpine, were thinned in 2004 with a primary goal of reducing fire severity through the removal of all ladder fuels and snags and the creation of an open canopy with wide, even spacing. In contrast, the forested area adjacent to the neighboring community of Nutrioso was thinned in 2010 with a goal of not only reducing fire severity, but of maintaining pockets of dense forest cover and associated wildlife habitat.
To characterize fire severity, the researchers established linear transects through each of these three study areas a year after the Wallow Fire. The transects ran in the direction of the fire's spread, from untreated to treated areas, and so represented a continuum of fire severity. The researchers then classified trees in each area based on the amount of fire damage they had sustained, using measures like crown scorch and bole char, and then ran statistical analyses that compared the relationship between severity measures and distance along the transect.
The study's findings showed that fire severity was reduced as the fire moved from untreated to treated areas, evidenced by the fire transitioning from a crown fire to a ground fire. But the distance at which the reduction occurred differed, depending on the intensity of the fuel treatment. The Alpine treatment area, which was more intensively thinned, achieved a spatially rapid reduction in severity, while the Nutrioso area required a wider area, although reduction was achieved before the fire reached the adjacent community. This would suggest that the greater a fuel treatment's emphasis on wildlife habitat and aesthetic considerations, the larger the size of treatment area needed to realize a reduction in fire severity. Both thinning prescriptions permitted firefighters to safely access the communities to extinguish fire starts and spot-protect homes.
"Our findings suggest that fuel treatments that promote wildlife habitat and aesthetics are still potentially successful in sufficiently reducing fire severity to provide opportunities to protect residences in the WUI during a fire," said Kennedy. "Although this case study refers to just these treatments in this particular fire, it does point to the possibility that there are multiple paths to effective fuel treatments."
INFORMATION:
The Pacific Northwest Research Station—headquartered in Portland, Ore.—generates and communicates scientific knowledge that helps people make informed choices about natural resources and the environment. The station has 11 laboratories and centers located in Alaska, Washington, and Oregon and about 400 employees. Learn more online at http://www.fs.fed.us/pnw.
Wallow Fire study suggests there may be multiple paths to fuel reduction in the WUI
Alternative fuel treatments both reduced fire behavior, allowed for protection of homes
2014-05-30
ELSE PRESS RELEASES FROM THIS DATE:
A first for NASA's IRIS: Observing a gigantic eruption of solar material
2014-05-30
VIDEO:
A coronal mass ejection burst off the side of the sun on May 9, 2014. The giant sheet of solar material erupting was the first CME seen by NASA's Interface...
Click here for more information.
A coronal mass ejection, or CME, surged off the side of the sun on May 9, 2014, and NASA's newest solar observatory caught it in extraordinary detail. This was the first CME observed by the Interface Region Imaging Spectrograph, or IRIS, which launched in June 2013 to peer into ...
Myriad presents data on BRACAnalysis CDx and HRD at 2014 ASCO meeting
2014-05-30
SALT LAKE CITY, Utah, May 30, 2014 – Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics, announced the presentation of new data at the American Society of Clinical Oncology (ASCO) meeting this week that supports the clinical efficacy of its BRACAnalysis CDx™ and HRD™ tests in predicting platinum based therapy response for breast cancer patients. Additionally, the company is providing an update on key commercial milestones that underscore its commitment to the field of companion diagnostics.
"Myriad is committed to advancing the science of companion ...
New method of wormlike motion lets gels wiggle through water
2014-05-30
Next time you spot an earthworm sliding through fresh dirt, take a closer look. What you're seeing is an organic movement called peristaltic locomotion that has been meticulously refined by nature.
Jarod Gregory, an undergraduate student in the University of Cincinnati's College of Engineering and Applied Science, used a worm's contracting and expanding motion to provide a way for gels to swim in water. This is a product of work by the interdisciplinary team consisting of Jarod Gregory, a chemical engineering major, and his two advisers, Lilit Yeghiazarian, assistant ...
New drug treatment helps prevent early menopause in breast cancer patients
2014-05-30
MAYWOOD, Ill. (May 30, 2014) – Among young women treated for breast cancer, one of the most distressing side effects of chemotherapy is early menopause. But a major clinical trial has found that the risk of early menopause can be significantly reduced by adding a drug called goserelin to the chemotherapy regimen. Also, women who took goserelin and wanted to have children were more likely to get pregnant and deliver a healthy baby.
Results were released during the 2014 American Society of Clinical Oncology 50th Annual Meeting in Chicago. Kathy Albain, MD, of Loyola University ...
Stopping statins may benefit terminally ill patients
2014-05-30
Results presented today at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) and June 6 at the European Association of Palliative Care Research Conference show that stopping statins for cholesterol management in the late stages of cancer or other terminal illnesses may offer quality-of-life and even life-extending benefits. The results highlight the larger question of when, if ever, it is appropriate in patients with life-limiting illnesses to discontinue medications prescribed for other conditions that will likely not lead to their death.
Researchers ...
Women with metastatic breast cancer can safely receive bisphosphonates less frequently, without comp
2014-05-30
CHICAGO – Women with metastatic breast cancer to the bone may be able to receive bisphosphonates, the bone-targeting class of drugs like zoledronic acid, less often after the first year of monthly administration. With that practice change, women may also reduce their risk of serious side effects, according to a study led by researchers at The University of Texas MD Anderson Cancer Center.
The research was presented today on the press program of the American Society of Clinical Oncology 2014 Annual Meeting by MD Anderson's Gabriel Hortobagyi, MD, professor, Breast Medical ...
Phase I study of DMOT4039A in patients with pancreatic or ovarian cancer
2014-05-30
A study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) describes the results of a phase I clinical trial of the investigational agent DMOT4039A against pancreatic and ovarian cancers. In this early clinical trial with the goal of identifying possible risks and defining likely dosages, the drug was well tolerated and in some patients showed initial evidence of anti-cancer activity.
The drug is in fact a combination of a chemotherapeutic agent with an antibody, technically called an antibody-drug conjugate (ADC). Just as cells ...
Genetic profile predicts which bladder cancer patients will benefit from early chemotherapy
2014-05-30
CHICAGO, IL (May 30, 2014)—Three genetic changes can predict whether a patient will benefit from chemotherapy before surgery to remove bladder cancer, according to new findings presented by Fox Chase Cancer Center researchers during the 50th Annual Meeting of the American Society of Clinical Oncology.
During the study, 36 patients with muscle-invasive bladder cancer received chemotherapy before surgery, consisting of an accelerated regimen of methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC). By the time surgery rolled around, 14 patients appeared cancer-free. ...
For the first time in the lab, researchers see stem cells take key step toward development
2014-05-30
CHAMPAIGN, Ill. — The gap between stem cell research and regenerative medicine just became a lot narrower, thanks to a new technique that coaxes stem cells, with potential to become any tissue type, to take the first step to specialization. It is the first time this critical step has been demonstrated in a laboratory.
University of Illinois researchers, in collaboration with scientists at Notre Dame University and the Huazhong University of Science and Technology in China, published their results in the journal Nature Communications.
"Everybody knows that for an embryo ...
Trial uncovers potential dangers of chemotherapy regimen for bladder cancer patients
2014-05-30
CHICAGO, IL (May 30, 2014)—Patients with muscle-invasive bladder cancer often benefit from chemotherapy before surgery to remove the tumor, but a test of one regimen by researchers at Fox Chase Cancer Center was halted when too many people experienced serious side effects such as heart attacks and blood clots in the legs and lungs.
All of the 31 patients included in the study received a combination of gemcitabine and cisplatin, two drugs normally administered for 12 weeks before surgery to remove the tumors. This became the standard of care after one study looked back, ...
LAST 30 PRESS RELEASES:
Farm robot autonomously navigates, harvests among raised beds
The bear in the (court)room: who decides on removing grizzly bears from the endangered species list?
First study reveals neurotoxic potential of rose-scented citronellol at high exposure levels
For a while, crocodile
Scientists find evidence that overturns theories of the origin of water on Earth
Foraging on the wing: How can ecologically similar birds live together?
Little birds’ personalities shine through their song – and may help find a mate
Primate mothers display different bereavement response to humans
New pollen-replacing food for honey bees brings new hope for survival
Gene-based blood test for melanoma may catch early signs of cancer’s return
Common genetic variants linked to drug-resistant epilepsy
Brisk walking pace + time spent at this speed may lower risk of heart rhythm abnormalities
Single mid-afternoon preventer inhaler dose may be best timing for asthma control
Symptoms of ice cold feet + heaviness in legs strongly linked to varicose veins
Brain areas necessary for reasoning identified
Growing wildflowers on disused urban land can damage bee health
Rapid rise in vaping in Britain has stalled
Young minds, big ideas: Florida’s first Invention Convention ignites innovation at USF
New study reveals how to make prescribed forest fires burn safer and cleaner
Inactive components in agricultural runoff may be hidden contributors to drinking water hazards
Colombia’s peatlands could be a crucial tool to fight climate change. But first we have to find them
Researchers refine a hybrid music therapy intervention for patients with cardiac and pulmonary conditions
Research Spotlight: Combining dexmedetomidine with spinal anesthesia prolongs pain relief and decreases shivering during surgery
Pennington Biomedical’s 2025 Bray Obesity Symposium to offer on-demand continuing education for physicians
Unlocking faster orthodontic treatments: the role of atf6 in bone remodeling
SwRI-led Lucy mission survey of main belt asteroid Donaldjohanson imminent
New bat cell lines and reagents help to study bat antiviral immune responses against hantaviruses and coronaviruses
Preterm birth might be predicted with high accuracy with new cheap, non-invasive test, based on cell-free DNA collected in standard early pregnancy testing
CVD researcher/clinician named editor-in-chief of Circulation: Genomic and Precision Medicine.
Holy shift: More Americans finding faith outside church
[Press-News.org] Wallow Fire study suggests there may be multiple paths to fuel reduction in the WUIAlternative fuel treatments both reduced fire behavior, allowed for protection of homes